To further explore the potential immune mechanism of MS4As in glioma, we analyzed correlations between MS4As with twenty-four immune inhibitory molecules, including ADORA2A, BTLA, CD160, CD244, CD274 (PDCD1LG1), CD96, CSF1R, CTLA4, HAVCR2, IDO1, IL10, IL10RB, KDR, KIR2DL1, KIR2DL3, LAG3, LGALS9, PDCD1, PDCD1LG2, NECTIN2, TGFB1, TGFBR1, TIGIT, and VTCN1 (Figure 10). This evidence concerns the gene ADORA2A and central nervous system cancer.